HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cholesteryl ester transfer protein and hepatic lipase gene polymorphisms: effects on hepatic mRNA levels, plasma lipids and carotid atherosclerosis.

AbstractOBJECTIVE:
HDL modifying effects of cholesteryl ester transfer protein (CETP) and hepatic lipase (LIPC) depend in part on each other. We studied associations of CETP-Taq1B and -514C>T-LIPC polymorphisms with hepatic mRNA levels, and their combined effects on plasma lipids and carotid atherosclerosis.
METHODS:
We genotyped the CETP-Taq1B and the -514C>T-LIPC polymorphisms in 67 obese women in whom hepatic CETP and LIPC transcript levels were determined as well as in 1549 participants of the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk (SAPHIR). Carotid atherosclerosis was assessed by intima-media thickness and extent of plaques (B-score) of the carotid arteries.
RESULTS:
In obese women, CETP-Taq1B and -514C>T-LIPC variant alleles were associated with reduced hepatic levels of CETP and LIPC mRNA, respectively. The CETP and LIPC polymorphisms accounted for 12.9 and 14.4% of the variability in respective transcripts. In the SAPHIR population, CETP-Taq1B showed independent effects on LDL diameter, HDL and LDL cholesterol, apolipoproteins AI and B and cholesterol/HDL cholesterol, while -514C>T-LIPC revealed independent effects on HDL cholesterol and apolipoprotein AI. The two polymorphisms displayed interactions at the level of HDL cholesterol. Compared to subjects carrying wild-type alleles at both loci, subjects homozygous for the CETP wild-type allele, but heterozygous for the LIPC polymorphism and subjects heterozygous for the CETP polymorphism, but homozygous for the LIPC wild-type allele showed an increased risk of carotid atherosclerosis (both P<0.05).
CONCLUSIONS:
CETP and LIPC polymorphisms influence the respective hepatic transcript levels, demonstrate interactions on HDL cholesterol and suggest that imbalances between CETP and LIPC activities may modulate the risk of carotid atherosclerosis.
AuthorsSelma M Soyal, Anton Sandhofer, Penelope Hahne, Hannes Oberkofler, Thomas Felder, Bernhard Iglseder, Karl Miller, Franz Krempler, Josef R Patsch, Bernhard Paulweber, Wolfgang Patsch
JournalAtherosclerosis (Atherosclerosis) Vol. 216 Issue 2 Pg. 374-80 (Jun 2011) ISSN: 1879-1484 [Electronic] Ireland
PMID21371711 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Cholesterol Ester Transfer Proteins
  • LIPC protein, human
  • Lipids
  • Lipoproteins, HDL
  • Lipase
Topics
  • Adult
  • Aged
  • Carotid Artery Diseases (genetics)
  • Cholesterol Ester Transfer Proteins (genetics)
  • Female
  • Genotype
  • Humans
  • Lipase (genetics)
  • Lipids (chemistry)
  • Lipoproteins, HDL (metabolism)
  • Liver (metabolism)
  • Male
  • Middle Aged
  • Obesity (complications)
  • Polymorphism, Genetic
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: